← Evidence map

ArticleJAC-antimicrobial resistance2023

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and

James A Karlowsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37577157